Patent 11576594 was granted and assigned to Tandem Diabetes Care on February, 2023 by the United States Patent and Trademark Office.
An apparatus including a controller can determine a rate of change of a blood glucose level of a subject from blood glucose data and determine if there is a risk of the blood glucose level going high or low.